-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $42

Benzinga·08/19/2026 17:42:08
語音播報
Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and raises the price target from $30 to $42.